Literature DB >> 8029455

Tumor gangliosides as targets for active specific immunotherapy of melanoma in man.

D L Morton1, M H Ravindranath, R F Irie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8029455     DOI： 10.1016/s0079-6123(08)61954-8

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN： 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  7 in total

1.  Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.

Authors:  E V Chandrasekaran; Jun Xue; Jie Xia; Robert D Locke; Shilpa A Patil; Sriram Neelamegham; Khushi L Matta
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

Review 2.  Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2015-05-09

3.  Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.

Authors:  Valérie Gouazé-Andersson; Jing Y Yu; Adam J Kreitenberg; Alicja Bielawska; Armando E Giuliano; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2007-11-09

Review 4.  Melanoma vaccines: mixed past, promising future.

Authors:  Junko Ozao-Choy; Delphine J Lee; Mark B Faries
Journal:  Surg Clin North Am       Date:  2014-08-07       Impact factor: 2.741

5.  Extended ultrastructural characterization of chordoma cells: the link to new therapeutic options.

Authors:  Dagmar Kolb; Elisabeth Pritz; Bibiane Steinecker-Frohnwieser; Birgit Lohberger; Alexander Deutsch; Thomas Kroneis; Amin El-Heliebi; Gottfried Dohr; Katharina Meditz; Karin Wagner; Harald Koefeler; Gerd Leitinger; Andreas Leithner; Bernadette Liegl-Atzwanger; Dagmar Zweytick; Beate Rinner
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

6.  Generation and characterization of a IgG monoclonal antibody specific for GM3 (NeuGc) ganglioside by immunizing β3Gn-T5 knockout mice.

Authors:  Dongwei He; Xiaoyan Fan; Boyi Liu; Yiqing Tian; Xiangmei Zhang; Lin Kang; Yan Tai; Shuzhen Liu; Qian Wang; Qingxia Li; Jianhui Cai
Journal:  Sci Rep       Date:  2018-02-07       Impact factor: 4.379

7.  Editorial for Special Issue "Gangliosides: Modes of Action and Cell Fates".

Authors:  Koichi Furukawa
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.